Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025

Core Insights - Royal Philips is introducing innovative technologies in radiation oncology at the ASTRO 2025 Annual Meeting, including the Philips Rembra RT and Areta RT CT platforms, which enhance accuracy and efficiency in radiation therapy [4][10] - The new helium-free BlueSeal RT 1.5T MR system is designed to improve simulation confidence and sustainability in radiation oncology [10][12] CT Platforms - The Rembra RT and Areta RT systems are engineered to expedite cancer treatment planning, providing clearer images and ultra-fast image reconstruction speeds of up to 106 images per second [7][8] - These systems feature a wide 85 cm extended field of view and next-generation 4DCT imaging capabilities, capturing a full respiratory cycle in one scan [7][8] - The platforms support remote collaboration for planning and training, enhancing efficiency without the need for additional staff [8] MR System - The BlueSeal RT system utilizes AI-powered SmartSpeed Precise software, enabling enhanced simulation confidence and reducing registration errors [10][11] - With approximately 2,000 helium-free MR scanners installed globally, Philips is leading the transition to sustainable MR technology [12] - The lightweight design of BlueSeal RT allows for flexible installation in various clinical environments, reducing costs and energy consumption [12][13] Industry Impact - Philips is setting new standards in radiation therapy with its innovative solutions, addressing the challenges of accuracy, workflow, and cost in oncology departments [9][13] - The integration of MVision AI's Contour+ software with Philips CT simulators is being explored to enhance automatic delineation of organs at risk [9]